Business
Chimeric Therapeutics (ASX:CHM) share price jumps 88% following its IPO
The Chimeric Therapeutics (ASX: CHM) share price had a very strong start to life as a listed company on Monday.
The drug development company’s shares jumped a whopping 88% at one stage to a high of 37.5 cents.
The Chimeric Therapeutics share price eventually closed the day at 29.5 cents, which is 47.5% higher than its Initial Public Offering (IPO) price of 20 cents.
The Chimeric Therapeutics IPO.
Chimeric Therapeutics’ shares landed on the ASX boards today following the completion of an IPO that raised $35 million from investors.
The offer comprised of 175 million shares to raise $35 million at an offer price of $0.20 per share, giving the company a market capitalisation of $66.1 million upon listing.
Management advised that…
-
Business20 hours agoWhere will Berkshire Hathaway be in 1 year?
-
Noosa News23 hours agoPolice reject claims about detained protester; SEQ train lines to be disrupted; BlueCare to cut enrolled nurses
-
Noosa News23 hours agoNick Cave and The Bad Seeds Are Bringing Their ‘Wild God’ Tour to Australia and New Zealand in 2026
-
Business22 hours agoWhat’s Bell Potter’s take on Endeavour Group shares following earnings results?